Welcome to the AAHP Virtual Journal Club page. This is where we host our monthly virtual journal clubs that have been prepared by residents here in Arkansas and then peer reviewed by preceptors or other pharmacists all over the state. The residents have broken down new articles into quick reads for our pharmacists to help you stay up to date on new studies. These articles will be broken down, much like you would see during a live journal club. A run down of the study background, population, intervention, and key takeaways are all highlighted in an easy to read format along with both the study author's conclusion as well as the reviewer's interpretation of how this trial impacts current practice. We plan on hosting a new trial every month. If you would like to get involved as a resident author or a peer reviewer or if you have an article you would like to see broken down in a review, please let us know at [email protected]. 

Virtual Journal Club Guide and Process

2022
March 28 - Trial of Pimavanserin in Dementia
February 28 - Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest
January 3 - Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

2021
November 23 - DATIPO: Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection
October 21 - Milrinone as Compared with Dobutamiune in the Treatment of Cardiogenic Shock
October 13 - Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
September 23 - Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes
August 19 - Colchicine in Patients with Chronic Coronary Disease
July 12 - Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis
June 23 - Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction (VICTORIA)
May 26 - Early Rhythm Control in Patients with Atrial Fibrillation
April 28 - Intravenous versus Oral Antibiotics for Eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CD)
March 15 - Dapagliflozin in Patients with Chronic Kidney Disease
March 15 - Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis (PROGRESS)
March 15 - Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women
November 30 - The RIVER Trial - Rivaroxaban versus Warfarin in Valvular A Fib
October 15 - Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced)
September 25 - Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF)
September 11 - Capstone-1 Trial - Single Dose Baloxavir for Uncomplicated Influenza
July 15 - Antithrombotic Therapy After Acute Coronary Syndrome or PCI in Atrial Fibrillation